Heart Disease and Hypertrophic Cardiomyopathy. Medically Reviewed by James Beckerman, MD, FACC on March 28, 2025. ... Hypertrophic Cardiomyopathy, Sudden Death, and Endocarditis.

Cytokinetics Incorporated (NASDAQ:CYTK) is one of the most active stocks to buy according to analysts. Earlier in May, ...

Hypertrophic cardiomyopathy (HCM) is a genetic disease that causes the heart muscle to become thicker, making it harder for the heart to pump blood.It's a condition that affects one in 200–500 people.

Hypertrophic cardiomyopathy (HCM) affects one in 500 people in the general population. In most cases, HCM is caused by genetic mutations. Doctors usually discover HCM during cardiac testing (an ...

Hypertrophic cardiomyopathy, also called HCM, is the leading cause of sudden cardiac death in young athletes, sometimes with no warning signs. It is characterized by the thickening and ...

Understanding the differences for hypertrophic cardiomyopathy is essential for improving care and supporting earlier diagnoses in Blacks.

A new therapy for managing ventricular hypertrophy in felines with subclinical hypertrophic cardiomyopathy (HCM) was ...

HCM is an incurable but often-undiagnosed type of heart disease that affects about one out of 500 people, some of whom will have a normal life expectancy but others who are at risk for ...

BOULDER, Colo., April 2, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced positive top-line data of EDG-7500 ...